Identification of Myocardial Disarray in Patients With Hypertrophic Cardiomyopathy and Ventricular Arrhythmias

[1]  Jonathan D. Suever,et al.  Evaluation of the impact of strain correction on the orientation of cardiac diffusion tensors with in vivo and ex vivo porcine hearts , 2018, Magnetic resonance in medicine.

[2]  Marcel P. Jackowski,et al.  Myocardial Scar Delineation Using Diffusion Tensor Magnetic Resonance Tractography , 2018, Journal of the American Heart Association.

[3]  Himanshu Bhat,et al.  Diffusion Tractography of the Entire Left Ventricle by Using Free-breathing Accelerated Simultaneous Multisection Imaging. , 2017, Radiology.

[4]  Eric Aliotta,et al.  Assessment of Myocardial Microstructural Dynamics by In Vivo Diffusion Tensor Cardiac Magnetic Resonance , 2017, Journal of the American College of Cardiology.

[5]  Holden H. Wu,et al.  Convex optimized diffusion encoding (CODE) gradient waveforms for minimum echo time and bulk motion–compensated diffusion‐weighted MRI , 2017, Magnetic resonance in medicine.

[6]  David Atkinson,et al.  Second‐order motion‐compensated spin echo diffusion tensor imaging of the human heart , 2016, Magnetic resonance in medicine.

[7]  B. Maron,et al.  Independent Assessment of the European Society of Cardiology Sudden Death Risk Model for Hypertrophic Cardiomyopathy. , 2015, The American journal of cardiology.

[8]  N. Geller,et al.  Hypertrophic Cardiomyopathy Registry: The rationale and design of an international, observational study of hypertrophic cardiomyopathy. , 2015, American heart journal.

[9]  C. Autore,et al.  Clinical Impact of Nonsustained Ventricular Tachycardia Recorded by the Implantable Cardioverter‐Defibrillator in Patients with Hypertrophic Cardiomyopathy , 2014, Journal of cardiovascular electrophysiology.

[10]  Frank B Sachse,et al.  Characterization of diffuse fibrosis in the failing human heart via diffusion tensor imaging and quantitative histological validation , 2014, NMR in biomedicine.

[11]  David Atkinson,et al.  Dual-Phase Cardiac Diffusion Tensor Imaging with Strain Correction , 2014, PLoS ONE.

[12]  Stefan Neubauer,et al.  Intercentre reproducibility of cardiac apparent diffusion coefficient and fractional anisotropy in healthy volunteers , 2014, Journal of Cardiovascular Magnetic Resonance.

[13]  M. Robson,et al.  T1 mapping for myocardial extracellular volume measurement by CMR: bolus only versus primed infusion technique. , 2013, JACC. Cardiovascular imaging.

[14]  P. Lambiase,et al.  A validation study of the 2003 American College of Cardiology/European Society of Cardiology and 2011 American College of Cardiology Foundation/American Heart Association risk stratification and treatment algorithms for sudden cardiac death in patients with hypertrophic cardiomyopathy , 2013, Heart.

[15]  D. Pennell,et al.  Reproducibility of in-vivo diffusion tensor cardiovascular magnetic resonance in hypertrophic cardiomyopathy , 2012, Journal of Cardiovascular Magnetic Resonance.

[16]  C. Autore,et al.  High risk for sudden death identified by electrocardiographic loop recording in a patient with hypertrophic cardiomyopathy without major risk factors. , 2011, The American journal of cardiology.

[17]  I. Kowalik,et al.  Implantable Cardioverter‐Defibrillator in Patients With Hypertrophic Cardiomyopathy: Efficacy and Complications of the Therapy in Long‐Term Follow‐up , 2010, Journal of cardiovascular electrophysiology.

[18]  M. Sheppard,et al.  Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy using cardiovascular magnetic resonance , 2010 .

[19]  Timothy G Reese,et al.  Imaging myocardial fiber disarray and intramural strain hypokinesis in hypertrophic cardiomyopathy with MRI , 2006, Journal of magnetic resonance imaging : JMRI.

[20]  Dudley J Pennell,et al.  The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. , 2004, Journal of the American College of Cardiology.

[21]  P. Elliott,et al.  Hypertrophic cardiomyopathy , 2004, The Lancet.

[22]  Timothy G Reese,et al.  Diffusion tensor MRI of myocardial fibers and sheets: Correspondence with visible cut‐face texture , 2003, Journal of magnetic resonance imaging : JMRI.

[23]  P. Elliott,et al.  Hypertrophic Cardiomyopathy: Histopathological Features of Sudden Death in Cardiac Troponin T Disease , 2001, Circulation.

[24]  W J McKenna,et al.  Relation between myocyte disarray and outcome in hypertrophic cardiomyopathy. , 2001, The American journal of cardiology.

[25]  B. Maron,et al.  Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population. , 2000, Circulation.

[26]  R L Winslow,et al.  Direct histological validation of diffusion tensor MRI in formaldehyde‐fixed myocardium , 2000, Magnetic resonance in medicine.

[27]  M. Link,et al.  Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. , 2000, The New England journal of medicine.

[28]  W. Roberts,et al.  Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death. , 2000, Journal of the American College of Cardiology.

[29]  John Forder,et al.  Histological validation of myocardial microstructure obtained from diffusion tensor magnetic resonance imaging. , 1998, American journal of physiology. Heart and circulatory physiology.

[30]  C. Henriquez,et al.  Magnetic resonance myocardial fiber-orientation mapping with direct histological correlation. , 1998, American journal of physiology. Heart and circulatory physiology.

[31]  C. Henriquez,et al.  Magnetic resonance myocardial fiber-orientation mapping with direct histological correlation. , 1998, The American journal of physiology.

[32]  B. Maron,et al.  Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population. , 1995, Journal of the American College of Cardiology.

[33]  R. Saumarez,et al.  Electrophysiological investigation of patients with hypertrophic cardiomyopathy. Evidence that slowed intraventricular conduction is associated with an increased risk of sudden death. , 1994, British heart journal.

[34]  C. Autore,et al.  Prognosis of Asymptomatic Patients With Hypertrophic Cardiomyopathy and Nonsustained Ventricular Tachycardia , 1994, Circulation.

[35]  W. Roberts,et al.  Myocardial disarray at junction of ventricular septum and left and right ventricular free walls in hypertrophic cardiomyopathy. , 1992, The American journal of cardiology.

[36]  M. Silver,et al.  An improved method for detecting and quantifying cardiac muscle disarray in hypertrophic cardiomyopathy. , 1989, American heart journal.

[37]  W. Roberts,et al.  Regional myocyte hypertrophy and increased interstitial myocardial fibrosis in hypertrophic cardiomyopathy. , 1987, The American journal of cardiology.

[38]  B. Maron,et al.  Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: a prospective study. , 1981, The American journal of cardiology.

[39]  W. Mckenna,et al.  Arrhythmia in hypertrophic cardiomyopathy. I: Influence on prognosis. , 1981, British heart journal.

[40]  A E Becker,et al.  Left ventricular fibre architecture in man. , 1981, British heart journal.

[41]  J. Ross,et al.  Fiber Orientation in the Canine Left Ventricle during Diastole and Systole , 1969, Circulation research.